Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby
Jehan A
JA
Department of Clinical Pathology, Tanta University, Faculty of Medicine, Tanta, Egypt.
Ahmed
Laila M Sayed
LM
Taha
Atef M
AM
Kamal
Oqasha
O
D000293:Adolescent; D000328:Adult; D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics*; D018572:Disease-Free Survival; D004534:Egypt; D005260:Female; D015870:Gene Expression / Q000235:genetics*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007621:Karyotyping; D007770:L-Lactate Dehydrogenase / Q000097:blood; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D007958:Leukocyte Count; D007963:Leukocytes, Mononuclear / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics*; D010976:Platelet Count; D018807:Polymorphism, Single-Stranded Conformational / Q000235:genetics*; D011379:Prognosis; D012008:Recurrence; D016019:Survival Analysis; D055815:Young Adult
C442828:BAALC protein, human; D022762:CCAAT-Enhancer-Binding Proteins; C515848:CEBPA protein, human; D006454:Hemoglobins; D009363:Neoplasm Proteins; D007770:L-Lactate Dehydrogenase